Rosiglitazone and Insulin Resistance in Renally Impaired Patients
NCT00452166
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
30
Enrollment
OTHER
Sponsor class
Stopped
it was not possible to recruit new patients anymore
Conditions
Chronic Kidney Disease
Insulin Resistance
Interventions
DRUG:
rosiglitazone
Sponsor
Leiden University Medical Center